Your browser doesn't support javascript.
loading
Treatment-related neuroendocrine prostate cancer managed with partial stereotactic ablative radiotherapy (P-SABR) for long-term survival: a case series.
Qi, Xin; Zhang, Zhuo-Fei; Gao, Xian-Shu; Qin, Shang-Bin; Bai, Yun; Yu, Wei; He, Qun; Fan, Yu; Zhang, Jian-Hua; Jiang, Yuan; He, Zhi-Song; Li, Hong-Zhen.
Afiliación
  • Qi X; Department of Radiation Oncology, Peking University First Hospital, Peking University, Beijing, China.
  • Zhang ZF; Department of Radiation Oncology, Peking University First Hospital, Peking University, Beijing, China.
  • Gao XS; Department of Radiation Oncology, Peking University First Hospital, Peking University, Beijing, China.
  • Qin SB; Department of Radiation Oncology, Peking University First Hospital, Peking University, Beijing, China.
  • Bai Y; Department of Radiation Oncology, Peking University First Hospital, Peking University, Beijing, China.
  • Yu W; Department of Urology, Peking University First Hospital, Peking University, Beijing, China.
  • He Q; Department of Urology, Peking University First Hospital, Peking University, Beijing, China.
  • Fan Y; Department of Urology, Peking University First Hospital, Peking University, Beijing, China.
  • Zhang JH; Department of Nuclear Medicine, Peking University First Hospital, Peking University, Beijing, China.
  • Jiang Y; Department of Medical Imaging, Peking University First Hospital, Peking University, Beijing, China.
  • He ZS; Department of Urology, Peking University First Hospital, Peking University, Beijing, China.
  • Li HZ; Department of Radiation Oncology, Peking University First Hospital, Peking University, Beijing, China.
Transl Androl Urol ; 12(1): 128-138, 2023 Jan 30.
Article en En | MEDLINE | ID: mdl-36760876

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transl Androl Urol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transl Androl Urol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: China